Illustrative cases
The COVARIS cases show how environmental context can be profiled and interpreted across different diseases, countries, regions and clinical trial design questions.
Together, they illustrate how environmental extrinsic factors can be translated into structured decision support before protocol lock, and into selected downstream context for interpretation and transferability.
They are not outcome-prediction or causal-effect cases.
Global COPD clinical trial geography — cumulative constrained scenario
Global COPD clinical trial geography — cumulative constrained scenario
This illustrative case tested whether a realistic five-country COPD clinical trial geography contained meaningful environmental stability differences before protocol lock.
Using a combined temperature-humidity respiratory weather-stress axis, the analysis showed that overall environmental dispersion could be reduced by 15.3% in a constrained scenario while retaining all countries and all zones.
A winter-only robustness view showed a smaller but still positive reduction of 5.4%.
IMMvent — supporting constrained what-if case
IMMvent — supporting constrained what-if case
This supporting case reconstructed a historical multinational phase 3 atopic dermatitis trial geography and tested whether a constrained alternative scenario could have produced a more environmentally stable setup under explicit assumptions.
The case shows that a public clinical trial geography can be reconstructed and tested through disciplined environmental scenario logic, providing useful context for future geography and protocol planning discussions.
It does not prove endpoint causality, sponsor ROI, sample-size reduction or actual patient-level exposure timing.
Atopic dermatitis humidity context case — disease-near environmental context case
Atopic dermatitis humidity context case — disease-near environmental context case
This disease-near case tested humidity-centered environmental profiling in atopic dermatitis, where humidity is a plausible contextual variable for disease activity, skin barrier conditions and measurement context.
The reconstructed multinational trial geography was not environmentally uniform: some countries appeared meaningfully drier, others more humid, and recent stability profiles differed. The case shows how humidity can add trial-planning context beyond a simple country list.
It does not show causal effects on AD outcomes, explain placebo response or translate environmental signals into clinical-effect claims.
COPD therapy case — transferability credibility case
COPD therapy case — transferability credibility case
This anonymized case compared a multinational COPD trial context with a national target context.
The national target context appeared consistently more humid than the reconstructed trial comparator, while air pollution was not a strong mismatch driver and cold-related burden was more mixed. The case shows how COVARIS can identify both supportive and non-supportive contextual findings.
It does not explain an HTA outcome, demonstrate treatment-effect modification or function as standalone HTA evidence.
What the cases show together
Taken together, these cases show that COVARIS can work in four closely related ways. It can detect meaningful environmental variation within countries and regions, support constrained scenario analysis of historical clinical trial geographies, profile disease-relevant contextual heterogeneity in multinational clinical trial settings, and structure transferability-oriented comparisons between trial context and target context.
Just as importantly, the cases show that COVARIS is not built to produce predetermined conclusions. Its value lies in making environmental context visible, comparable and relevant to decisions before protocol lock – and, in selected adjacent settings, in making contextual differences more explicit and less anecdotal.
The cases should not be read as arguing that phase 3 trials ought to eliminate real-world variation. They argue for making environmental context explicit early enough to judge whether it looks acceptable, excessive, or avoidable in the planned clinical trial geography.
COVARIS helps sponsors and CROs screen planned trial countries, regions and enrollment windows for disease-relevant environmental instability before protocol lock.
COVARIS does not predict outcomes or prove causal effects. It provides planning-stage environmental context intelligence for sponsor-led clinical trial decisions.
COVARIS ApS
2100 Copenhagen
Denmark
+45 25 30 30 28
CVR-no.: 46484673